CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
DAILY EQUITY REPORT 25TH SEPTEMBER 2014
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report
INDIAN FACE
INDIAN MARKET INDICES
CLOSE
PREVIOUS
SENSEX
26744.69
26775.69
NIFTY
8002.40
8017.55
INDIAN EQUITY BENCHMARK ended flat, amid a choppy trading session, as investors turned cautious ahead of the expiry
ASIAN MARKET
of September derivative contracts while the Supreme Court's
INDICES
CLOSE
PREVIOUS
NIKKEI
16167.45
16205.90
HANG SENG
23921.61
23837.07
KOSPI
2035.64
2028.91
decision on coal blocks weighed on select metal and power stocks.
Further, Inox Leisure were up nearly 4% ahead of the board meet tomorrow to merge its wholly-owned subsidiary with itself.
SECTORIAL INDICES INDICES
CLOSE
CHANGE (%)
CNX 100
7931.85
-0.22
S&P CNX 500
6437.25
-0.43
CNX MIDCAP
11397.85
-0.73
CNX 200
4072.15
-0.34
BANK NIFTY
15740.30
-1.02
GLOBAL FACE
TOP GAINERS SCRIPT
CLOSE
CHANGE (%)
COAL INDIA
351.50
4.88
CIPLA
602.90
3.18
HUL
764.70
3.05
DLF
160.20
3.02
Amtek to focus on non-auto biz like mining, oil & gas.
Asian stock market closed mixed while Europe is trading flat as concerns on global growth and unrest in Syria dominate sentiment.
European stocks were steady to lower in choppy trade as Tuesday's downbeat euro zone data continued to weigh and markets eyed an upcoming report on Germany's business climate.
TOP LOSERS SCRIPT
CLOSE
CHANGE (%)
JINDAL STEEL
188.55
-10.60
PNB
921.00
-4.67
SBIN
2476.00
-3.14
TATA STEEL
470.95
-3.02
U.S. stocks market coupled with fears conflicts in the Middle East could slow global recovery.
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report MARKET MOVERS UPSIDE
NIFTY SPOT
SCRIPT
CLOSE
ONGC
413.70
CHANGE (%) 1.57
ITC
377.20
1.73
S3
4.83
7814
COAL INDIA INFY
351.35 3644.80
1.05
TREND
STRATEGY
BULLISH
BUY ON DIPS PIVOT POINTS P R1
S2
S1
7906
7954
7998
8046
SUPPORT S1-7950 S2-7925
NIFTY
R2
R3
8090
8182
RESISTANCE R1-8050 R2-8070
MARKET MOVERS DOWNSIDE SCRIPT
CLOSE
TCS
2643.00
CHANGE (%) [1.68]
RELIANCE
965.05
[0.08]
SBI
2486.35
[2.73]
ICICI BANK
1516.40
[1.44]
FII & DII ACTIVITY INSTITUTION
NET BUY (CR.)
NET SELL (CR)
FII
5200.31
5007.75
DII
1858.96
1533.26
BANK NIFTY FUTURE TREND BULLISH PIVOT POINTS S3
NSE TOTALS
15130
INDICES
ADVANCES
DECLINES
NIFTY
22
27
BANK NIFTY
2
10
STRATEGY BUY ON DIPS
S2
S1
P
R1
15457
15600
15783
15926
BANK NIFTY
SUPPORT S1-15640 S2-15500
R2
R3
16109 16435 RESISTANCE R1-15965 R2-16230
CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report r
MARKET TALKS
SC cancels some allocated since 1993
coal
construction and delivery of 16 mobile substation containing
blocks
The Supreme Court, in a landmark judgment today, said that all
31.5MVA transformers from Iraq Government.
coal blocks were cancelled except four government-run non-joint
State Bank of India board approves stock split
venture allotments. The apex court in an order today cancelled 214 allocated coal mines out of 218. The ruling sent shares of Jindal
State Bank of India (SBI) has approved sub division of its shares
Steel and Power Ltd , Hindalco Industries and Tata Power sharply
following stock split announcement from other leading lenders like
lower.
ICICI Bank, Punjab National Bank and Axis Bank.The board of directors of the bank, in a meeting on September 24, decided to
reduce the face value of equity shares of the bank from Rs 10 per
Titan board to spin off Precision Engineering Division
share to Re 1 per share and to increase the number of issued shares in proportion thereof.
Titan Company Ltd has announced that the Board of Directors of the Company at its meeting held on September 23, 2014, has taken an in-principle decision to spin off the Precision Engineering
Dr Reddys announces the launch Levalbuterol Inhalation Solution
Division of the Company as a wholly owned subsidiary, subject to applicable approvals.
Dr Reddy's Laboratories announced today that it has launch Levalbuterol Inhalation Solution, USP 0.31 mg/3 mL, 0.63 mg/3 mL,
Crompton Greaves bags Rs150 crore contract from Iraq
1.25 mg/ 3 mL Unit-Dose Vials, a therapeutic equivalent generic version of XOPENEX (levalbuterol hydrochloride) inhalation solution in the US market on September 23, 2014, approved by the United
Crompton Greaves awarded $25mn contract for design,
States Food & Drug Administration.
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary authority over your trading or investment accounts. All rights reserved.